EB-5 Investors Receive Full Repayment of $60 Million Loan

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
99
EB-5 Investors Receive Full Repayment of $60 Million Loan in New York City Regional Center’s Brooklyn Navy Yard Offering

New York, NY , Jan. 04, 2017 (GLOBE NEWSWIRE) -- The New York City Regional Center is pleased to announce the repayment of its $60 million EB-5 loan used to assist the continued redevelopment of the Brooklyn Navy Yard, New York City’s largest industrial park.  The borrower of the EB-5 capital was the Brooklyn Navy Yard Development Corporation.  The $60 million investment and resulting job creation enabled 359 individuals (EB-5 investors and family members) to receive permanent residency in the United States under the EB-5 Immigrant Investor Program.  They are among the more than 2,400 individuals who have achieved permanent residency in the United States through New York City Regional Center offerings to date.     

The $60 million of EB-5 capital helped fund a key phase of redevelopment at the Brooklyn Navy Yard (“Navy Yard”), an industrial park owned by the City of New York.  Over the past few years, the City of New York has embarked on the largest expansion of the Navy Yard in 65 years.  The redevelopment of the Navy Yard is a key element of the City’s plan to refurbish its industrial manufacturing sector and create additional jobs. 

The $60 million loan from the New York City Regional Center provided much needed capital for the renovation of a 215,000 square foot industrial building that was previously used as a machine shop for the United States Navy during World War II but had sat vacant for decades.  The project transformed the building, now named the Green Manufacturing Center, into New York City’s leading hub for green manufacturing and sustainable design.  EB-5 capital was also used to assist with surrounding infrastructure improvements in the Navy Yard such as the building of new roads, water and sewer lines, and pile foundations and bulkhead walls to allow for the continued use of dry docks and adjacent berths to support maritime activity in the New York harbor. 

“The repayment of the $60 million loan is a major event for the 120 EB-5 investors in this offering,” said Paul Levinsohn, Managing Principal of the New York City Regional Center. “We take seriously our role in spurring job creation and economic development in New York City as well as our responsibility to assist our EB-5 investors and their families.  We extend our best wishes to them on their continued journey.”  

“We are pleased that our first loan in the Navy Yard has been repaid,” added George L. Olsen, Managing Principal of the New York City Regional Center.  “This repayment is a milestone for our company and for our EB-5 investors and their families.” 

The repaid $60 million loan is one of seven New York City Regional Center EB-5 loans totaling $339 million being used for critical projects in the Navy Yard.  Since 2009, EB-5 capital from the New York City Regional Center has directly helped implement a broad range of new construction, infrastructure and building improvements, and the renovation of over 1.2 million square feet of vacant and dilapidated buildings in the Navy Yard. 

“Over the past eight years, the New York City Regional Center has provided over $300 million of financing to fund a series of job-creating projects in the Navy Yard.  We are pleased to play an integral role in the transformation of this industrial park.” said Mr. Levinsohn.

The New York City Regional Center was approved by the United States Citizenship and Immigration Services in 2008 to secure foreign investment for real estate and infrastructure projects within Brooklyn, Queens, Manhattan, and the Bronx under the EB-5 Immigrant Investor Program.  It was the first EB-5 regional center approved in New York City and has secured over $1.3 billion of capital for 21 economic development projects throughout the city.   

In addition to projects in the Navy Yard, the New York City Regional Center has provided capital to assist with the redevelopment of the George Washington Bridge Bus Station and the construction of a wireless infrastructure network in New York City’s subway stations.  The New York City Regional Center is providing capital for the redevelopment of a new cargo facility at JFK International Airport and the construction of Fresh Direct’s new headquarters in the South Bronx.  New York City Regional Center funding is also being used for construction of the City Point development in downtown Brooklyn, a new medical office/hotel complex in Washington Heights, and the expansion of the Hutchinson Metro Center in the Bronx.  The New York City Regional Center is securing capital to help fund the construction of LinkNYC, the public-private initiative that is bringing the nation’s largest and fastest public Wi-Fi network to the streets of New York City. 

In addition to helping fuel economic development, New York City Regional Center offerings have enabled over 2,400 individuals to become permanent residents of the United States through the EB-5 Immigrant Investor Program.  To date, investors in its offerings have received over 2,340 I-526 petition approvals and over 800 I-829 approvals.  Over 5,000 EB-5 investors and family members in New York City Regional Center offerings have also received conditional residency in the United States.

“We are extremely proud of our track record over the past eight years.  We look forward to continuing this success for our investors and their families,” said Mr. Olsen.

For more information about the New York City Regional Center, please visit www.nycrc.com .

NYCRC 1-212-619-1270

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles